BioSpace News Archive

Societal CDMO, Inc., a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, announced that it has been awarded a new manufacturing and packaging task order agreement by the National Cancer Institute’s Division of Cancer Treatment and Diagnosis.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that it has kicked off the first production run of the second quarter for its recombinant spider silk.

Anavex Life Sciences Corp. announced presentations of Psychometric Evaluation of the Rett Syndrome Behaviour Questionnaire and Burden of Illness study in Rett syndrome by the respective working groups, at the IRSF Rett Syndrome Scientific Meeting, taking place in Nashville, TN, April 26–27, 2022.

XRHealth, the gateway to the healthcare metaverse, announces today their virtual/augmented reality therapy is now available in the United States to treat patients with autism.

Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2022.

NeoImmuneTech, Inc. today announced it will present new clinical data for its lead asset NT-I7 (efineptakin alfa) across three presentations at the American Society of Clinical Oncology (ASCO) annual meeting, to be held in Chicago, June 3-7, 2022.

Catamaran Bio , Inc. today announced the appointment of Cherry Thomas, MD, as Chief Medical Officer.

Rocket Pharmaceuticals, Inc . today announces that Kinnari Patel, Pharm.D., MBA, President and Chief Operating Officer, will deliver an in-person company presentation at the Bank of America Securities Healthcare Conference on Wednesday, May 11 at 2:20 p.m. ET.

Data from Independent, Pooled Analysis Show Significantly Improved Risk Predictions Over Clinical Variables for TissueCypher ® Barrett’s Esophagus Test and Ability to Identify Patients at High Risk of Progressing to Esophageal Cancer/

ZAP Surgical Systems, Inc. today announced that Baptist Health South Florida, will acquire the ZAP-X® Gyroscopic Radiosurgery® platform for cranial stereotactic radiosurgery (SRS). The ZAP-X will be used by Miami Neuroscience Institute, in collaboration with Miami Cancer Institute, both part of Baptist Health South Florida, dedicated to offering the most innovative and advanced techniques to diagnose and treat brain disorders and tumors.